Aceclofenac tablets manufacturers & suppliers

Aceclofenac Tablets

Form: Oral Tablets

Strength: 100 mg

Reference Brands: Aceclo(EU)

Category: Analgesic

Aceclofenac tablets are approved in the EU and several other countries for managing pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. In the EU, brands like Aceclo and Acegloc are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. Regulatory approval involves comprehensive clinical data, quality assurance, and pharmacovigilance commitments. In countries where aceclofenac is approved, manufacturers must adhere to national regulatory standards, ensuring safe use. For detailed dossier preparation, regulatory compliance, and registration assistance, visit PharmaTradz. We support efficient market access for aceclofenac tablets, helping you navigate complex regulatory landscapes seamlessly and ensuring adherence to European standards for safe, effective analgesic therapy.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Paracetamol (Acetaminophen) Injection

Strength: 1000 mg/100 mL (10 mg/mL)

Form: Injectable solution

Reference Brands: Ofirmev

View Details
Dexketoprofen + Tramadol Tablets

Strength: 25 mg dexketoprofen + 37.5 mg tramadol

Form: Tablets

Reference Brands: Enantyum(EU)

View Details
Paracetamol + Codeine Tablets

Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg

Form: Tablets

Reference Brands: Tylenol with Codeine(US)

View Details
Aceclofenac + Paracetamol Tablets

Strength: 100 mg Aceclofenac + 325 mg Paracetamol

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.